Follow on Google News News By Tag * Life Sciences * Biotech * Pharma * Clinical Development * Kinase Inhibitors * Report * Commercial * Kinase * Pipeline Assessment * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | Insight Pharma Report Announces the Kinase Therapeutics ReportKinase Therapeutics: Pipeline Assessment and Commercial Prospects
By: Insight Pharma Reports The number of kinase inhibitors entering clinical development has increased significantly in recent years. In addition to major pharmaceutical and biotech companies, an increasing number of emerging companies are focusing on their development. By 2020, small-molecule kinase inhibitors could generate annual revenues > $25 billion. This report assesses: • R&D considerations specific to targeting kinases • Current kinase inhibitor pipelines • Commercial successes to date • Near- and longer-term market outlook • Corporate activities of firms involved with kinases For more information and to purchase this Insight Pharma Report, visit: www.InsightPharmaReports.com About Insight Pharma Reports Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. www.InsightPharmaReports.com # # # Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|